Clinical Trial Update: Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

View source ↗

Summary

A clinical trial aims to develop and apply a thrombosis risk prediction model in lung cancer patients treated with immune checkpoint inhibitors; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thromboembolism
• Lung Cancer
• Venous Thromboembolism

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Lung Cancer, Venous Thromboembolism | Status: RECRUITING